Open access
Aug 2026
Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer
A previously undescribed expression signature with potential predictive value for bevacizumab benefit is identified, and transcriptional heterogeneity of ovarian cancer that extends beyond current molecular classifications is revealed.
O. Zolotareva, K. Legler, O. Tsoy et al.
· Genome Medicine · 0 citations